Clopidogrel loading offers little added benefit for stenosis patients pre-TAVI

P2Y12 inhibitor initiation with clopidogrel using a loading dose (LD) is no more effective in reducing ischemic events or adverse outcomes in transcatheter aortic valve implantation (TAVI) patients than initiating the therapy without a loading dose, according to research published in the American Journal of Cardiology Feb. 10.

Keck Medicine of USC Announces Acquisition of Los Angeles Cardiology Associates

Newswise — LOS ANGELES – Keck Medicine of USC announces the acquisition of Los Angeles Cardiology Associates, a cardiovascular care group with eight locations across the Los Angeles region. This acquisition, effective Feb. 24, 2019, expands the cardiovascular care provided by Keck Medicine of USC and adds 11 physicians to the institution’s roster of faculty cardiologists.